5,044 Shares in The Cigna Group (NYSE:CI) Bought by Coldstream Capital Management Inc.

Coldstream Capital Management Inc. bought a new position in The Cigna Group (NYSE:CI – Get Rating) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 5,044 shares of the health services provider’s stock, valued at approximately $1,671,000.

Several other large investors have also made changes to their positions in CI. Hexagon Capital Partners LLC raised its position in shares of The Cigna Group by 178.4% in the 3rd quarter. Hexagon Capital Partners LLC now owns 103 shares of the health services provider’s stock worth $29,000 after buying an additional 66 shares during the period. Nelson Van Denburg & Campbell Wealth Management Group LLC raised its position in The Cigna Group by 32.3% in the third quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 401 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 98 shares during the period. Householder Group Estate & Retirement Specialist LLC purchased a new position in The Cigna Group in the third quarter valued at about $34,000. Wagner Wealth Management LLC purchased a new position in The Cigna Group in the second quarter valued at about $35,000. Finally, Pittenger & Anderson Inc. raised its position in The Cigna Group by 40.0% in the third quarter. Pittenger & Anderson Inc. now owns 140 shares of the health services provider’s stock valued at $39,000 after purchasing an additional 40 shares during the period. 87.61% of the stock is owned by hedge funds and other institutional investors.

The Cigna Group Stock Down 1.8 %

NYSE:CI opened at $269.45 on Friday. The company has a market capitalization of $80.04 billion, a price-to-earnings ratio of 12.60, a price-to-earnings-growth ratio of 0.97 and a beta of 0.67. The Cigna Group has a one year low of $238.48 and a one year high of $340.11. The stock has a 50-day simple moving average of $296.46 and a 200 day simple moving average of $304.55. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.70 and a current ratio of 0.70.

The Cigna Group (NYSE:CI – Get Rating) last issued its earnings results on Friday, February 3rd. The health services provider reported $4.96 EPS for the quarter, beating analysts’ consensus estimates of $4.84 by $0.12. The Cigna Group had a return on equity of 16.01% and a net margin of 3.69%. The company had revenue of $45.75 billion during the quarter, compared to the consensus estimate of $45.79 billion. During the same period in the previous year, the firm posted $4.77 earnings per share. The Cigna Group’s quarterly revenue was up .1% compared to the same quarter last year. Sell-side analysts predict that The Cigna Group will post 24.92 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 23rd. Shareholders of record on Wednesday, March 8th will be paid a $1.23 dividend. This is an increase from The Cigna Group’s previous quarterly dividend of $1.12. This represents a $4.92 dividend on an annualized basis and a yield of 1.83%. The ex-dividend date is Tuesday, March 7th. The Cigna Group’s payout ratio is presently 23.01%.

Wall Street Analysts Forecast Growth

Several research analysts have commented on CI shares. Wells Fargo & Company lowered The Cigna Group from an “overweight” rating to an “equal weight” rating and cut their price objective for the company from $370.00 to $355.00 in a research report on Tuesday, January 3rd. Loop Capital cut their price objective on The Cigna Group from $350.00 to $320.00 in a research report on Monday, February 6th. Morgan Stanley raised their price objective on The Cigna Group from $347.00 to $365.00 and gave the company an “overweight” rating in a research report on Friday, January 6th. SVB Leerink lifted their target price on The Cigna Group from $309.00 to $335.00 and gave the stock a “market perform” rating in a research report on Wednesday, February 8th. Finally, StockNews.com raised The Cigna Group from a “buy” rating to a “strong-buy” rating in a research report on Wednesday. Seven research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $339.00.

Insider Buying and Selling at The Cigna Group

In other The Cigna Group news, insider Michael W. Triplett sold 1,731 shares of The Cigna Group stock in a transaction that occurred on Friday, March 10th. The stock was sold at an average price of $271.67, for a total value of $470,260.77. Following the completion of the transaction, the insider now directly owns 30,235 shares in the company, valued at $8,213,942.45. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, CEO David Cordani sold 20,148 shares of the business’s stock in a transaction that occurred on Monday, February 27th. The stock was sold at an average price of $294.06, for a total transaction of $5,924,720.88. Following the completion of the transaction, the chief executive officer now directly owns 120,496 shares in the company, valued at $35,433,053.76. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Michael W. Triplett sold 1,731 shares of the business’s stock in a transaction that occurred on Friday, March 10th. The stock was sold at an average price of $271.67, for a total value of $470,260.77. Following the transaction, the insider now owns 30,235 shares of the company’s stock, valued at $8,213,942.45. The disclosure for this sale can be found here. Insiders sold a total of 27,752 shares of company stock worth $8,008,479 over the last ninety days. Company insiders own 0.80% of the company’s stock.

The Cigna Group Company Profile

(Get Rating)

The Cigna Group is engaged in the provision of global health services. It operates through the following segments: Evernorth, U.S. Medical, International Markets, and Group Disability and Other. The Evernorth segment includes a broad range of coordinated and point solution health services, including pharmacy solutions, benefits management solutions, care solutions and intelligence solutions.